Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	0.18	-0.68	0.29	0.07
Net Debt / Equity Ratio	-5.98	4.24	-13.48	-1.75
Net Debt / EBITDA Ratio	0.77	0.43	0.51	0.49
Quick Ratio	1.35	1.23	2.41	1.22
Current Ratio	1.43	1.55	2.45	1.23
Return on Equity (ROE)	-	-	-369.43%	-
Return on Assets (ROA)	-	-55.30%	-58.56%	-
Return on Capital Employed (ROCE)	-200.90%	-134.00%	-151.50%	-353.90%
Buyback Yield / Dilution	-3.81%	-1.33%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q